Greg Freiherr, Industry Consultant

Greg Freiherr has reported on developments in radiology since 1983. He runs the consulting service, The Freiherr Group.

Blog | Greg Freiherr, Industry Consultant | August 11, 2011

Trump Card in the Deck of Hybrids

In the yesteryears of over-optimism, when medical imaging was in its heyday, magnetic resonance spectroscopy (MRS) was framed as a kind of digital phantom that would one day wrest the biopsy needle from the hands of oncologists. MRS, with its graphs and hard numbers characterizing the metabolites present in tissue, would illuminate the biochemical fingerprint of cancer.  

That pipe dream went up in smoke as the 20th century drew to a close, when MRS advocates were seen as victims of the da Vinci syndrome – that ideas, while reasonable, were not feasible because technology was not yet up to the task. The past decade, however, has swept much of the technological challenge aside. The adoption of 3T, which began in earnest midway through the last decade, along with the evolution of 1.5T scanners with the horsepower to do MRS, has put spectroscopy at the fingertips of many in routine clinical practice. Vendors offer training courses in its use. Yet, very little has changed.

Despite a cornucopia of MRS packages – some so easy even a gecko could run them – spectroscopy remains largely a research tool, driven by forward-thinking, forward-looking visionaries.  One reason is that long-repeated practices are hard to change…and needle biopsy is one of the longest. Another is that functional imaging, namely positron emission tomography/computed tomography (PET/CT), is widely available and its usage is still trending upward, albeit less so than a few years ago.

Given these incontrovertible facts, needle biopsy will likely remain the go-to procedure for definitively diagnosing cancer. And similarly, PET/CT will likely remain the modality of choice in diagnostic workup and patient followup after therapy.

Yet, a strong case can be made for routine use of MR spectroscopy in oncology, if for no other reasons than the convenience of the provider and better service to the patient. Virtually every oncology patient has at least one MR exam. With the right software and hardware in place, adding a six-minute sequence to the standard brain exam provides baseline numbers from healthy neighboring tissue while another six-minute sequence plumbs the nearby lesion, producing spectra that in many cases can distinguish healthy from malignant tissue.

Granted, these spectra will not supplant a needle biopsy. And the extra time and effort will not be reimbursed. Consequently, any additional costs to upgrade the scanner to support spectroscopy may be tough to justify. But this justification does not have to come from the need to generate revenue so much as to ensure its source. We are at a time when the value that radiology brings to medicine is being questioned. Tiny ultrasound scanners peek out from the shirt pockets of general practitioners; a 1980s rock band promotes digital radiography on a music video; CT scanners capable of every major radiological exam are going for well under a million dollars.

By contrast, MR spectroscopy remains firmly rooted in radiology. It’s fast. It’s relatively easy to understand – although its results take time to grasp. And its use demonstrates the commitment of radiologists to patient welfare, supplanting conventional thought, which is to judge therapeutic success on the basis of whether a lesion has grown or shrunk. The hard numbers derived from MRS could help determine whether a patient is responding just days after the start of therapy. Compare this instantaneity to the weeks or months that must pass before tumor growth or shrinkage is evident.

MR spectroscopy is the ultimate hybrid imaging technology, delivering both anatomical and functional imaging in a single exam. As such, it may not only be the most underplayed card in imaging’s deck, it could be trump.
 

Related Content

ASNC and SNMMI Release Joint Document on Diagnosis, Treatment of Cardiac Sarcoidosis
News | Cardiac Imaging | August 18, 2017
August 18, 2017 — The American Society of Nuclear Cardiology (ASNC) has released a joint expert consensus document wi
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
Study Demonstrates First Human Application of Novel PET Tracer for Prostate Cancer

Transaxial 11Csarcosine hybrid PET/CT showed a (triangulated) adenocarcinoma in the transition zone of the anterior right prostate gland on PET (A), CT (B), and a separately obtained T2?weighted MR sequence (C) with resulting PET/MRI registration (D). Image courtesy of M. Piert et al., University of Michigan, Ann Arbor, Mich.

News | Radiopharmaceuticals and Tracers | August 16, 2017
In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the...
Patient Complexity, Subspecialization Impact List Prices for Radiologists' Services
News | Business | August 15, 2017
A new study by the Harvey L. Neiman Health Policy Institute finds that patient condition complexity and...
Upcoming radiology conferences, meetings and events.
News | August 14, 2017
ITN maintains a comprehensive listing of radiology specialty meetings on its website at ...
ACR Establishes Education Committee for Patient- and Family-Centered Care
News | Patient Engagement | August 09, 2017
Members of the new Education Committee of the American College of Radiology (ACR) Commission on Patient- and Family-...
ACR Annual Conference on Quality and Safety Offers Strategies for Radiology Practices
News | Business | August 08, 2017
The American College of Radiology (ACR) Annual Conference on Quality and Safety, scheduled for Oct. 13-14 in Boston,...
Sponsored Content | Videos | Business | July 28, 2017
Angelic McDonald, MSRS, CRA, FAHRA, regional director of imaging, Baylor Scott & White Health and the president-e
Radiation dose tracking in medical imaging is helping increase patient safety by lower X-ray doses.
Feature | Radiation Dose Management | July 26, 2017 | Dave Fornell
Patient X-ray radiation exposure from medical imaging has been a hot topic in radiology the past few years and has pr
Overlay Init